CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Wolfe Upgrades Biogen to Outperform From Peer Perform, Price Target is $300

Positive
AI Analysis

Summary

Wolfe Research upgraded Biogen to Outperform from Peer Perform with a $300 price target. This is an analyst rating change with no material catalyst or clinical/regulatory event.

Importance:3/10
Sentiment:
0.70
analyst_upgradeprice_targetrating_change
Related Companies

Read the original article

Published by yahoo_finance on August 13, 2026 11:25 AM

Read Original